Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22010914 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial
Condition: Tuberculosis
Intervention: Drug: Meloxicam 7.5mg daily for 8 weeks
2 Completed
Has Results
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
Conditions: HIV Infection;   Tuberculosis
Interventions: Other: Strategy: Immediate ART;   Other: Strategy:  Deferred ART

Indicates status has not been verified in more than two years